Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
3.24M
-
Shares change
-
+93.8K
-
Total reported value, excl. options
-
$34M
-
Value change
-
+$1.03M
-
Number of buys
-
8
-
Number of sells
-
-5
-
Price
-
$10.52
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2017
18 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q4 2017.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.24M shares
of 29.1M outstanding shares and own 11.13% of the company stock.
Largest 10 shareholders include FMR LLC (1.2M shares), RA CAPITAL MANAGEMENT, LLC (700K shares), Knoll Capital Management, LP (300K shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (300K shares), Tourbillon Capital Partners, L.P. (252K shares), BAKER BROS. ADVISORS LP (200K shares), Artal Group S.A. (150K shares), Vanguard Group Inc (74.1K shares), MILLENNIUM MANAGEMENT LLC (25.3K shares), and GOLDMAN SACHS GROUP INC (22K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.